Alkermes
ALKS
#2530
Rank
NZ$12.71 B
Marketcap
NZ$75.80
Share price
-7.11%
Change (1 day)
59.82%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): NZ$0.40 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.56 Billion. In 2025 the company made an earning of NZ$0.53 Billion a decrease over its 2024 earnings that were of NZ$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.40 B-24.6%
2025 NZ$0.53 B-34.87%
2024 NZ$0.81 B-17.97%
2023 NZ$0.99 B-468.52%
2022 -NZ$0.27 Billion449.24%
2021 -NZ$49.07 Million-68.04%
2020 -NZ$0.16 Billion-52.1%
2019 -NZ$0.33 Billion64.49%
2018 -NZ$0.2 Billion-15.04%
2017 -NZ$0.23 Billion-34.2%
2016 -NZ$0.35 Billion-5.34%
2015 -NZ$0.37 Billion35084.97%
2014 -NZ$1.05 Million
2012 NZ$12.96 M-117.81%
2011 -NZ$72.82 Million-12.69%
2010 -NZ$83.41 Million94.3%
2009 -NZ$42.93 Million-117.7%
2008 NZ$0.24 B622.63%
2007 NZ$33.55 M
2004 -NZ$0.14 Billion-14.48%
2003 -NZ$0.16 Billion11.88%
2002 -NZ$0.14 Billion39.65%
2001 -NZ$99.34 Million5.73%
2000 -NZ$93.95 Million-28.91%
1999 -NZ$0.14 Billion237.28%
1998 -NZ$39.19 Million100.05%
1997 -NZ$19.59 Million-37.93%
1996 -NZ$31.56 Million82.72%
1995 -NZ$17.27 Million-26.79%
1994 -NZ$23.59 Million-72.78%
1993 -NZ$86.66 Million208.07%
1992 -NZ$28.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.57 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.50 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.37 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.76 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.61 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.38 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.48 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.96 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel